Risa Terasawa
Takatsuki, 5698686, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A Case of Gastric Metastasis from Breast Cancer Detected 12 Years after Surgery
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 24, 2025
Successful Ninth-Line Therapy with Trastuzumab Deruxtecan in Recurrent Breast Cancer with Low HER2 Expression-A Case Report
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 18, 2025
A Case of Recurrent Breast Cancer with Delayed Wound Healing Induced by Bevacizumab
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: March 18, 2024
A Case of Severe Drug-Induced Lung Injury during Preoperative Chemotherapy for Breast Cancer in the Early Stages of the COVID-19 Epidemic
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 22, 2024
A Case of COVID-19 Infection during Postoperative Chemotherapy for Breast Cancer Treated with Antibody Cocktail Therapy to Prevent Disease Aggravation
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 06, 2023
ESR1 Mutation-Positive Recurrent Breast Cancer Successfully Treated with Letrozole plus Abemaciclib
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 23, 2023
A Case Study of Successful Breast Cancer Treatment after Recovery from Drug-Induced Interstitial Lung Disease
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 23, 2023
Olaparib Could Be Re-Administered after Chemotherapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: April 17, 2023
De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: March 08, 2019
A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes.
Journal: Cancer chemotherapy and pharmacology
Published: November 10, 2017
A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy.
Journal: Anticancer research
Published: October 21, 2016
A Case of Squamous Cell Carcinoma of the Breast
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 17, 2016
Last Updated: 09/26/2026